<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Carcinog</journal-id><journal-id journal-id-type="iso-abbrev">Mol. Carcinog</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)1098-2744</journal-id><journal-id journal-id-type="publisher-id">MC</journal-id><journal-title-group><journal-title>Molecular Carcinogenesis</journal-title></journal-title-group><issn pub-type="ppub">0899-1987</issn><issn pub-type="epub">1098-2744</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28418082</article-id><article-id pub-id-type="pmc">5573932</article-id><article-id pub-id-type="doi">10.1002/mc.22666</article-id><article-id pub-id-type="publisher-id">MC22666</article-id><article-categories><subj-group subj-group-type="overline"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Non&#x02010;digestible carbohydrates supplementation increases <italic>miR&#x02010;32</italic> expression in the healthy human colorectal epithelium: A randomized controlled trial</article-title><alt-title alt-title-type="left-running-head">MALCOMSON <sc>et al.</sc></alt-title></title-group><contrib-group><contrib id="mc22666-cr-0001" contrib-type="author"><name><surname>Malcomson</surname><given-names>Fiona C</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5072-7644</contrib-id><xref ref-type="aff" rid="mc22666-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="mc22666-cr-0002" contrib-type="author"><name><surname>Willis</surname><given-names>Naomi D</given-names></name><xref ref-type="aff" rid="mc22666-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="mc22666-cr-0003" contrib-type="author"><name><surname>McCallum</surname><given-names>Iain</given-names></name><xref ref-type="aff" rid="mc22666-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="mc22666-cr-0004" contrib-type="author"><name><surname>Xie</surname><given-names>Long</given-names></name><xref ref-type="aff" rid="mc22666-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="mc22666-cr-0005" contrib-type="author"><name><surname>Lagerwaard</surname><given-names>Bart</given-names></name><xref ref-type="aff" rid="mc22666-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="mc22666-cr-0006" contrib-type="author"><name><surname>Kelly</surname><given-names>Seamus</given-names></name><xref ref-type="aff" rid="mc22666-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="mc22666-cr-0007" contrib-type="author"><name><surname>Bradburn</surname><given-names>D. Michael</given-names></name><xref ref-type="aff" rid="mc22666-aff-0003">
<sup>3</sup>
</xref></contrib><contrib id="mc22666-cr-0008" contrib-type="author"><name><surname>Belshaw</surname><given-names>Nigel J</given-names></name><xref ref-type="aff" rid="mc22666-aff-0004">
<sup>4</sup>
</xref></contrib><contrib id="mc22666-cr-0009" contrib-type="author"><name><surname>Johnson</surname><given-names>Ian T</given-names></name><xref ref-type="aff" rid="mc22666-aff-0004">
<sup>4</sup>
</xref></contrib><contrib id="mc22666-cr-0010" contrib-type="author" corresp="yes"><name><surname>Mathers</surname><given-names>John C</given-names></name><address><email>john.mathers@newcastle.ac.uk</email></address><xref ref-type="aff" rid="mc22666-aff-0001">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="mc22666-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Human Nutrition Research Centre, Institute of Cellular Medicine, Newcastle University</named-content>
<institution>Campus for Ageing and Vitality</institution>
<named-content content-type="city">Newcastle upon Tyne</named-content>
<country country="GB">UK</country>
</aff><aff id="mc22666-aff-0002">
<label><sup>2</sup></label>
<institution>Northumbria Healthcare NHS Foundation Trust</institution>
<named-content content-type="city">North Shields</named-content>
<country country="GB">UK</country>
</aff><aff id="mc22666-aff-0003">
<label><sup>3</sup></label>
<institution>Northumbria Healthcare NHS Foundation Trust</institution>
<named-content content-type="city">Ashington</named-content>
<country country="GB">UK</country>
</aff><aff id="mc22666-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Institute of Food Research</named-content>
<institution>Norwich Research Park</institution>
<named-content content-type="city">Norwich</named-content>
<named-content content-type="country-part">Norfolk</named-content>
<country country="GB">UK</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
John C Mathers, Human Nutrition Research Centre, Institute of Cellular Medicine, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne, NE4 5PL, UK.<break/>
Email: 
<email>john.mathers@newcastle.ac.uk</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>09</day><month>5</month><year>2017</year></pub-date><pub-date pub-type="ppub"><month>9</month><year>2017</year></pub-date><volume>56</volume><issue>9</issue><issue-id pub-id-type="doi">10.1002/mc.v56.9</issue-id><fpage>2104</fpage><lpage>2111</lpage><history><date date-type="received"><day>12</day><month>12</month><year>2016</year></date><date date-type="rev-recd"><day>31</day><month>3</month><year>2017</year></date><date date-type="accepted"><day>13</day><month>4</month><year>2017</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2017 Wiley Periodicals, Inc. <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2017 The Authors. <italic>Molecular Carcinogenesis</italic> Published by wiley periodicals, Inc.</copyright-statement><license license-type="creativeCommonsBy"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:MC-56-2104.pdf"/><abstract><p>Colorectal cancer (CRC) risk is modulated by diet and there is convincing evidence of reduced risk with higher non&#x02010;digestible carbohydrates (NDCs) consumption. Resistant starch (RS), a NDC, positively modulates the expression of oncogenic microRNAs, suggesting that this could be a mechanism through which NDCs protect against CRC. The present study aimed to investigate the effects of supplementation with two NDCs, RS, and polydextrose (PD), on microRNA expression in the macroscopically&#x02010;normal human rectal epithelium using samples from the DISC Study, a randomized, double&#x02010;blind, placebo&#x02010;controlled dietary intervention. We screened 1008 miRNAs in pooled post&#x02010;intervention rectal mucosal samples from participants allocated to the double placebo group and those supplemented with both RS and PD. A total of 111 miRNAs were up&#x02010; or down&#x02010;regulated by at least twofold in the RS&#x02009;+&#x02009;PD group compared with the control group. From these, eight were selected for quantification in individual participant samples by qPCR, and fold&#x02010;change direction was consistent with the array for seven miRNAs. The inconsistency for <italic>miR&#x02010;133b</italic> and the lower fold&#x02010;change values observed for the seven miRNAs is probably because qPCR of individual participant samples is a more robust and sensitive method of quantification than the array. <italic>miR&#x02010;32</italic> expression was increased by approximately threefold (<italic>P</italic>&#x02009;=&#x02009;0.033) in the rectal mucosa of participants supplemented with RS&#x02009;+&#x02009;PD compared with placebo. <italic>miR&#x02010;32</italic> is involved in the regulation of processes such as cell proliferation that are dysregulated in CRC. Furthermore, <italic>miR&#x02010;32</italic> may affect non&#x02010;canonical NF&#x02010;&#x003ba;B signaling via regulation of <italic>TRAF3</italic> expression and consequently <italic>NIK</italic> stabilization.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="mc22666-kwd-0001">colorectal cancer</kwd><kwd id="mc22666-kwd-0002">microRNA</kwd><kwd id="mc22666-kwd-0003">non&#x02010;digestible carbohydrates</kwd></kwd-group><funding-group><award-group><funding-source>Biotechnology and Biological Sciences Research Council</funding-source><award-id>BB/H005013/1</award-id></award-group></funding-group><counts><fig-count count="2"/><table-count count="3"/><page-count count="8"/><word-count count="5080"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>component-id</meta-name><meta-value>mc22666</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>September 2017</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.1.8 mode:remove_FC converted:29.08.2017</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="mc22666-cit-000A">
<string-name>
<surname>Malcomson</surname>
<given-names>FC</given-names>
</string-name>, 
<string-name>
<surname>Willis</surname>
<given-names>ND</given-names>
</string-name>, 
<string-name>
<surname>McCallum</surname>
<given-names>I</given-names>
</string-name>, et al. <article-title>Non&#x02010;digestible carbohydrates supplementation increases <italic>miR&#x02010;32</italic> expression in the healthy human colorectal epithelium: A randomized controlled trial</article-title>. 
<source>Molecular Carcinogenesis</source>. 
<year>2017</year>;<volume>56:</volume>
<fpage>2104</fpage>&#x02013;<lpage>2111</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/mc.22666">https://doi.org/10.1002/mc.22666</ext-link>
<pub-id pub-id-type="pmid">28418082</pub-id></mixed-citation>
</p></notes><notes><fn-group><fn id="mc22666-note-0004"><p>Trial registration: The DISC Study is registered with <ext-link ext-link-type="uri" xlink:href="http://ClinicalTrials.gov">ClinicalTrials.gov</ext-link> (NCT01214681).</p></fn></fn-group></notes></front><body><def-list list-content="abbreviations" id="mc22666-dl-0001"><title>Abbreviations</title><def-item><term id="mc22666-ldef-0001">CRC</term><def id="mc22666-ldef-0002"><p>colorectal cancer</p></def></def-item><def-item><term id="mc22666-ldef-0003">HDAC</term><def id="mc22666-ldef-0004"><p>histone deacetylase</p></def></def-item><def-item><term id="mc22666-ldef-0005">miRNA</term><def id="mc22666-ldef-0006"><p>microRNA</p></def></def-item><def-item><term id="mc22666-ldef-0007">NDC</term><def id="mc22666-ldef-0008"><p>non&#x02010;digestible carbohydrates</p></def></def-item><def-item><term id="mc22666-ldef-0009">PD</term><def id="mc22666-ldef-0010"><p>polydextrose</p></def></def-item><def-item><term id="mc22666-ldef-0011">RS</term><def id="mc22666-ldef-0012"><p>resistant starch</p></def></def-item><def-item><term id="mc22666-ldef-0013">SCFA</term><def id="mc22666-ldef-0014"><p>short chain fatty acid</p></def></def-item></def-list><sec id="mc22666-sec-0002"><label>1</label><title>INTRODUCTION</title><p>Colorectal cancer (CRC) is the third most common cancer worldwide and fourth most common cause of cancer&#x02010;related death.<xref rid="mc22666-bib-0001" ref-type="ref">1</xref> CRC risk is significantly modulated by lifestyle factors including diet. The World Cancer Research Fund/American Institute for Cancer report concluded that there is convincing evidence for lower CRC risk with higher consumption of dietary fibre.<xref rid="mc22666-bib-0002" ref-type="ref">2</xref> This includes non&#x02010;digestible carbohydrates (NDCs), such as resistant starch (RS) and polydextrose (PD), that resist digestion in the small intestine and are fermented by bacteria in the large bowel to produce the short&#x02010;chain fatty acids (SCFAs) butyrate (the preferred energy source for colonocytes), propionate and acetate.</p><p>Butyrate, produced primarily by bacterial species of the <italic>Clostridia, Roseburia</italic>, and <italic>Eubacteria</italic> genera,<xref rid="mc22666-bib-0003" ref-type="ref">3</xref> has chemoprotective anti&#x02010;inflammatory and anti&#x02010;proliferative properties and regulates apoptosis in both normal and cancerous cells.<xref rid="mc22666-bib-0004" ref-type="ref">4</xref>, <xref rid="mc22666-bib-0005" ref-type="ref">5</xref> Butyrate has effects on epigenetic mechanisms that regulate gene expression and are important in colorectal tumorigenesis, including its role as a histone deacetylase inhibitor (HDACi)<xref rid="mc22666-bib-0006" ref-type="ref">6</xref> and effects on microRNA (miRNA) expression.<xref rid="mc22666-bib-0007" ref-type="ref">7</xref>, <xref rid="mc22666-bib-0008" ref-type="ref">8</xref>
</p><p>miRNAs are small, non&#x02010;coding RNAs that regulate the expression of their target genes at a post&#x02010;transcriptional level by degrading messenger RNA or blocking translation. Over 1500 miRNAs have been identified in humans and have been predicted to regulate the expression of up to 60% of genes,<xref rid="mc22666-bib-0009" ref-type="ref">9</xref>, <xref rid="mc22666-bib-0010" ref-type="ref">10</xref> consequently regulating multiple biological processes including cell proliferation, differentiation, and apoptosis. Abnormal miRNA expression is observed in colorectal tissue as well as plasma, urine, and stool samples from CRC patients.<xref rid="mc22666-bib-0011" ref-type="ref">11</xref>, <xref rid="mc22666-bib-0012" ref-type="ref">12</xref>
</p><p>miRNA expression is modulated by multiple dietary factors; for example the expression of 250, 198, and 99 miRNAs was associated with intakes of carbohydrate, sucrose, and wholegrains, respectively, and some of these miRNAs showed differential expression between normal and tumor tissue.<xref rid="mc22666-bib-0013" ref-type="ref">13</xref> A limited number of studies have investigated the effects of NDCs and butyrate on miRNA expression in the cells from the large bowel epithelium, and the majority of studies investigating the role of miRNAs in colorectal carcinogenesis have been performed in CRC cell lines or using tissue from resected tumors. Using a microarray&#x02010;based approach, Humphreys and colleagues observed that treatment of HT&#x02010;29 colorectal adenocarcinoma cells with 5&#x02009;mM butyrate for 48&#x02009;h altered the expression 69 miRNAs.<xref rid="mc22666-bib-0014" ref-type="ref">14</xref> Follow&#x02010;up analysis by qPCR showed that butyrate treatment reduced expression of miRNAs belonging to the oncogenic <italic>miR&#x02010;17&#x02010;92</italic> cluster and decreased cell proliferation. Hu et al also reported that butyrate exposure altered expression of 44 miRNAs in HCT&#x02010;116 cells, 18 of which were confirmed by qPCR.<xref rid="mc22666-bib-0007" ref-type="ref">7</xref> Humphreys et al were the first to investigate the effects of RS and butyrate on expression of <italic>miR&#x02010;17&#x02010;92</italic> cluster members in a human intervention study.<xref rid="mc22666-bib-0015" ref-type="ref">15</xref> Supplementation of a high red meat diet, which increased <italic>miR&#x02010;17&#x02010;92</italic> expression by approximately 30%, with butyrylated RS for 4 wk restored expression to baseline levels, suggesting that RS reversed the detrimental effects of red meat on expression of oncogenic miRNAs.</p><p>In the current study, we hypothesised that NDCs are protective against CRC by regulating the expression of miRNAs, in particular by down&#x02010;regulating expression of miRNAs that are upregulated in CRC. For the first time, we used a whole miRNome PCR array to screen for candidate miRNAs that are differentially expressed in the macroscopically&#x02010;normal rectal mucosa of healthy participants following supplementation with two NDCs (RS and PD). We validated the findings from the miRNome array for eight miRNAs by qPCR using RNA samples from 29 individual participants.</p></sec><sec id="mc22666-sec-0003"><label>2</label><title>METHODS</title><sec id="mc22666-sec-0004"><label>2.1</label><title>Study participants</title><p>Participants were recruited from gastroenterology out&#x02010;patients departments at North Tyneside General Hospital, North Shields, UK and Wansbeck General Hospital, Ashington, UK between May 2010 and July 2011. The exclusion criteria included being aged &#x0003c;16 or &#x0003e;85 years, being a prisoner at the time of endoscopy, being pregnant, or planning to become pregnant, diabetes mellitus, familial adenomatous polyposis syndrome, Lynch Syndrome, known colorectal tumor or prior colorectal cancer, prior colorectal resection, active colonic inflammation at endoscopy, iatrogenic perforation at endoscopy, incomplete left&#x02010;sided examination, colorectal carcinoma discovered at endoscopy, CRC on histology, chemotherapy in the last 6 months, administering non&#x02010;steroidal anti&#x02010;inflammatories, anti&#x02010;coagulants, or immunosuppressive medication.</p></sec><sec id="mc22666-sec-0005"><label>2.2</label><title>Intervention methodology</title><p>The samples utilized for the present study were collected as part of the DISC Study, a double&#x02010;blind, randomized, placebo&#x02010;controlled dietary intervention that supplemented healthy participants with RS and/or PD for 50&#x02009;d in a 2&#x02009;&#x000d7;&#x02009;2 factorial design.<xref rid="mc22666-bib-0016" ref-type="ref">16</xref> For the purpose of this study, the following two groups of participants were used:
<list list-type="bullet" id="mc22666-list-0001"><list-item id="mc22666-ldef-0015"><p>Double placebo (Control): 12&#x02009;g of Maltodextrin and 23&#x02009;g of Amioca starch.</p></list-item><list-item id="mc22666-ldef-0016"><p>Double intervention (RS&#x02009;+&#x02009;PD): 23&#x02009;g of Hi&#x02010;maize&#x000ae; 260 and 12&#x02009;g of Litesse&#x000ae; <italic>Ultra</italic>&#x02122;. For the purposes of this paper, this group is described as the Intervention group.</p></list-item></list>
</p><p>Anthropometric measurements were taken at baseline and post&#x02010;intervention. Participants also completed a food frequency questionnaire and a lifestyle questionnaire that collected information on physical activity and smoking status.</p></sec><sec id="mc22666-sec-0006"><label>2.3</label><title>Human colorectal tissue samples</title><p>This study was approved by the Newcastle and North Tyneside Research Ethics Committee (REC No. 09/H0907/77). Mucosal biopsies from the rectum (10&#x02009;cm from the ano&#x02010;rectal verge) were collected pre&#x02010;intervention at endoscopy (colonoscopy or flexible sigmoidoscopy) and post&#x02010;intervention at rigid sigmoidoscopy.</p></sec><sec id="mc22666-sec-0007"><label>2.4</label><title>Study design</title><p>We designed a two&#x02010;phase study to identify miRNAs modulated by NDCs (see Fig. <xref rid="mc22666-fig-0001" ref-type="fig">1</xref>). In the screening phase, we pooled equivalent amounts of cDNA reverse&#x02010;transcribed from RNA extracted from the rectal mucosa of each of 15 Control participants (supplemented with double placebo) and of 14 Intervention participants (supplemented with RS and PD). Abundance of 1008 miRNAs was quantified in each pooled sample by qPCR using the Human miRNome miScript&#x000ae; miRNA PCR array (Qiagen). A total of 111 miRNAs were up&#x02010; or down&#x02010;regulated by more than twofold in the Intervention compared with the Control sample. This number was reduced to 29 miRNAs by excluding those which did not have a Ct value of &#x0003c;30 in at least one of the samples. From these, a total of seven miRNAs were selected to be validated by qPCR in the individual pre&#x02010; and post&#x02010;intervention rectal mucosa samples. In addition, <italic>miR&#x02010;32</italic> was selected for quantification by qPCR due to its role in colorectal carcinogenesis.<xref rid="mc22666-bib-0017" ref-type="ref">17</xref>
</p><fig fig-type="Figure" xml:lang="en" id="mc22666-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Flow&#x02010;chart showing the study design and selection of miRNAs for quantification in individual samples by qPCR. From 1008 miRNAs quantified, 111 miRNAs showed a difference in expression between pooled control and intervention samples. From these, eight miRNAs were selected for quantification in individual participant samples</p></caption><graphic id="nlm-graphic-1" xlink:href="MC-56-2104-g001"><permissions><copyright-holder>Copyright &#x000a9; 2017 Wiley Periodicals, Inc.</copyright-holder></permissions></graphic></fig></sec><sec id="mc22666-sec-0008"><label>2.5</label><title>Isolation of total RNA</title><p>Total RNA was extracted from half a rectal mucosal biopsy using the miRNeasy Mini Kit (Qiagen, UK) following the manufacturer's instructions. Tissue disruption was performed by shaking the tissues with five 3&#x02009;mm glass beads (VWR, UK) for 1&#x02009;m in QIAzol Lysis Reagent (miRNeasy Mini Kit) using an amalgamator. The lysate and beads were transferred to QiaShredders (Qiagen, UK) for homogenization by centrifugation for 2&#x02009;m at maximum speed. RNA was eluted in 30&#x02009;&#x000b5;L of RNase&#x02010;free water. Concentration and RNA purity were determined using the NanoDrop 1000 spectrophotometer (Thermo Scientific) and NanoDrop 1000 Software version 3.7.1. RNA integrity was assessed by agarose gel electrophoresis.</p></sec><sec id="mc22666-sec-0009"><label>2.6</label><title>Synthesis of cDNA</title><p>cDNA was synthesized from 0.8&#x02009;&#x003bc;g of RNA using the miScript II RT Kit (Qiagen) as described by the manufacturer. The miScript HiSpec Buffer (5&#x000d7;) was used during reverse transcription to enable subsequent quantification of mature miRNAs. The samples were incubated for 60&#x02009;m at 37&#x000b0;C followed by 5&#x02009;m at 95&#x000b0;C using the Sensoquest lab cycler (G&#x000f6;ttingen, Germany).</p></sec><sec id="mc22666-sec-0010"><label>2.7</label><title>miRNome array</title><p>Prior to analyses, cDNA samples were diluted ten times. Expression of 1008 miRNAs plus six quality controls and six reference RNAs were quantified by qPCR using the 96 well plate Human miRNome miScript&#x000ae; miRNA PCR array (Qiagen) as described by the manufacturer (see Fig. <xref rid="mc22666-fig-0001" ref-type="fig">1</xref>). miRNAs with Ct values over 35 were classed as undetected. Raw data were normalized against the six reference RNAs and, as subsequent validation of miRNA expression by qPCR was normalized against only two reference RNAs, also against the selected two reference RNAs (<italic>RNU&#x02010;6</italic> and <italic>SNORD68</italic>) to check that these data were comparable with both normalization methods. Technical performance of the plates was checked using the integrated quality controls included on all the array plates.</p></sec><sec id="mc22666-sec-0011"><label>2.8</label><title>Validation of miRNA expression by quantitative PCR</title><p>Quantification of the eight selected miRNAs for validation and two reference RNAs (<italic>SNORD68</italic> and <italic>RNU&#x02010;6</italic>) in individual samples was performed by qPCR using the Applied Biosystems&#x000ae; StepOnePlus&#x02122; system, the miScript SYBR Green PCR Kit and custom miScript primer assays (Qiagen, UK) as described by the manufacturer.</p><p>Prior to analysis of the qPCR data, the melt curves were checked for a single peak and a constant threshold value was set for each miRNA separately for all of the samples by taking the average of the set thresholds for each miRNA for every plate. Ct values greater than 35 were classed as undetected and raw data were normalized relative to the geometric mean of <italic>RNU&#x02010;6</italic> and <italic>SNORD68</italic>.</p></sec><sec id="mc22666-sec-0012"><label>2.9</label><title>Statistical analyses</title><p>The data, expressed as adjusted relative copies (2<sup>&#x02212;&#x00394;Ct</sup>&#x02009;&#x000d7;&#x02009;1000, relative to the geometric mean of <italic>SNORD68</italic> and <italic>RNU&#x02010;6</italic>), were analyzed using Minitab&#x000ae; v.17. Prior to analyses, data were checked for a normal distribution using the Kolmogorov&#x02010;Smirnov test. Data that were not normally&#x02010;distributed were transformed appropriately, using log<sub>10</sub> or by taking the square root.</p><p>Differences between the two treatment groups were analyzed using the ANOVA General Linear Model (GLM), adjusting for pre&#x02010;intervention expression, age, gender, endoscopy procedure, smoking status, and BMI as covariates.</p></sec></sec><sec id="mc22666-sec-0013"><label>3</label><title>RESULTS</title><sec id="mc22666-sec-0014"><label>3.1</label><title>Participant characteristics</title><p>Samples from a total of 29 participants were utilized for this study, comprising 15 Control participants and 14 Double Intervention participants. Participant characteristics are summarized in Table <xref rid="mc22666-tbl-0001" ref-type="table-wrap">1</xref>.</p><table-wrap id="mc22666-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p>Participant characteristics for vontrol and RS&#x02009;+&#x02009;PD groups</p></caption><table frame="below" rules="groups"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><thead valign="bottom"><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Variable</th><th align="left" valign="bottom" rowspan="1" colspan="1">Control</th><th align="left" valign="bottom" rowspan="1" colspan="1">RS&#x02009;+&#x02009;PD</th><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic>P</italic>&#x02010;value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">N</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Age</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Mean (years)</td><td align="left" rowspan="1" colspan="1">49.2</td><td align="left" rowspan="1" colspan="1">51.1</td><td align="left" rowspan="1" colspan="1">0.669</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Range (years)</td><td align="left" rowspan="1" colspan="1">30&#x02010;70</td><td align="left" rowspan="1" colspan="1">36&#x02010;74</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Gender</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Female (%)</td><td align="left" rowspan="1" colspan="1">7 (47)</td><td align="left" rowspan="1" colspan="1">3 (21)</td><td align="left" rowspan="1" colspan="1">0.256</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Male (%)</td><td align="left" rowspan="1" colspan="1">8 (53)</td><td align="left" rowspan="1" colspan="1">11 (79)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Ethnicity</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Caucasian (%)</td><td align="left" rowspan="1" colspan="1">14 (93)</td><td align="left" rowspan="1" colspan="1">14 (100)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Black african (%)</td><td align="left" rowspan="1" colspan="1">1 (7)</td><td align="left" rowspan="1" colspan="1">0 (0)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Endoscopy procedure</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Colonoscopy (%)</td><td align="left" rowspan="1" colspan="1">3 (20)</td><td align="left" rowspan="1" colspan="1">3 (21)</td><td align="left" rowspan="1" colspan="1">0.924</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Flexible sigmoidoscopy (%)</td><td align="left" rowspan="1" colspan="1">12 (80)</td><td align="left" rowspan="1" colspan="1">11 (79)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">BMI</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Mean (kg/m<sup>2</sup>)</td><td align="left" rowspan="1" colspan="1">29.7</td><td align="left" rowspan="1" colspan="1">29.7</td><td align="left" rowspan="1" colspan="1">0.971</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Range (kg/m<sup>2</sup>)</td><td align="left" rowspan="1" colspan="1">23.5&#x02010;37.0</td><td align="left" rowspan="1" colspan="1">23.5&#x02010;40.0</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Smoking status</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Never (%)</td><td align="left" rowspan="1" colspan="1">7 (46.6)</td><td align="left" rowspan="1" colspan="1">4 (28.6)</td><td align="left" rowspan="1" colspan="1">0.553</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Former (%)</td><td align="left" rowspan="1" colspan="1">4 (26.7)</td><td align="left" rowspan="1" colspan="1">6 (42.8)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Current (%)</td><td align="left" rowspan="1" colspan="1">4 (26.7)</td><td align="left" rowspan="1" colspan="1">4 (28.6)</td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><permissions><copyright-holder>&#x000a9; 2017 Wiley Periodicals, Inc.</copyright-holder></permissions></table-wrap><p>Mean age of participants in both groups was similar (49 and 51 years for Control and RS&#x02009;+&#x02009;PD, respectively), with the youngest participant being aged 30 and oldest aged 74. With the exception of one Control participant, all participants were Caucasian. In both groups, colonoscopy was the main endoscopy procedure at baseline. The participants were well&#x02010;matched for BMI (most were overweight or obese) and smoking behavior (73% and 71% were never or former smokers for Control and RS&#x02009;+&#x02009;PD groups, respectively). The observed similarity in participant characteristics is evidence of the success of the randomization process.</p></sec><sec id="mc22666-sec-0015"><label>3.2</label><title>Human miRNome miScript miRNA PCR array</title><p>The expression of 1008 miRNAs was quantified in pooled post&#x02010;intervention samples from participants in the Control and from the RS&#x02009;+&#x02009;PD group using Qiagen's Human miRNome array. All of the array plates passed the quality control checks. A total of 217 miRNAs (Ct values &#x02265;35), equating to 22% of the 1008 quantified miRNAs, were undetected in one or both of the Control and RS&#x02009;+&#x02009;PD samples. The proportions of miRNAs in each Ct value range were comparable for both the Control and Intervention samples (Fig. <xref rid="mc22666-fig-0002" ref-type="fig">2</xref>A).</p><fig fig-type="Figure" xml:lang="en" id="mc22666-fig-0002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Whole miRNome PCR array (A) proportion of miRNAs with Ct values in different ranges, (B) correlation of data presented as fold&#x02010;change normalised relative to <italic>RNU&#x02010;6</italic> and <italic>SNORD&#x02010;68</italic> versus all six reference miRNAs, and miRNAs showing (C) &#x02265;2&#x02010;fold up&#x02010;regulation and (D) &#x02265;2&#x02010;fold down&#x02010;regulation in the RS&#x02009;+&#x02009;PD group compared with the Control group</p></caption><graphic id="nlm-graphic-3" xlink:href="MC-56-2104-g002"><permissions><copyright-holder>Copyright &#x000a9; 2017 Wiley Periodicals, Inc.</copyright-holder></permissions></graphic></fig><p>A cut&#x02010;off value of twofold difference (up&#x02010; or down&#x02010;regulated) in expression, relative to all six reference RNAs, for the miRNAs between the RS&#x02009;+&#x02009;PD group and the Control group was used as an index of potentially differentially&#x02010;expressed miRNAs. A total of 33 miRNAs were up&#x02010;regulated &#x02265;2&#x02010;fold and 78 miRNAs were down&#x02010;regulated &#x02265;2&#x02010;fold in the Intervention compared with Control sample (Additional File 2).</p></sec><sec id="mc22666-sec-0016"><label>3.3</label><title>Normalization of PCR array data</title><p>Raw data were normalized relative to all six reference RNAs included on the array plates and to the two selected reference RNAs (<italic>RNU&#x02010;6</italic> and <italic>SNORD68)</italic> used during the validation stage of the study. We checked that both normalization methods were comparable for all 111 miRNAs showing a fold&#x02010;change&#x02009;&#x02265;&#x02009;2 (Fig. <xref rid="mc22666-fig-0002" ref-type="fig">2</xref>B). From the 1008 miRNAs for which there were probes on the array, 69 miRNAs showed &#x02265;2&#x02010;fold difference in expression when normalized relative to only <italic>RNU&#x02010;6</italic> and <italic>SNORD&#x02010;68</italic> compared with 111 for normalization to all six reference RNAs. In all cases where the normalization methods resulted in different fold&#x02010;change results, fold&#x02010;changes were very small (between &#x02212;1.13 and 1.12) and the difference in fold&#x02010;change between the two normalization methods did not exceed 0.14.</p></sec><sec id="mc22666-sec-0017"><label>3.4</label><title>Selection of miRNAs for individual participant analysis</title><p>From the analysis of the 1008 miRNAs, two lists were compiled comprising miRNAs with &#x02265;2&#x02010;fold up&#x02010; or down&#x02010;regulation, which included a total of 111 miRNAs. Each list was then analyzed individually and those with a comment of &#x0201c;OKAY&#x0201d; or &#x0201c;A&#x0201d; on the miScript miRNA PCR Array Data Analysis Web Portal output were selected; this reduced the number of miRNAs to six up&#x02010;regulated &#x02265;2&#x02010;fold and 23 down&#x02010;regulated &#x02265;2&#x02010;fold. The miScript miRNA PCR Array Data Analysis Web Portal defined a comment of &#x0201c;OKAY&#x0201d; as a miRNA with reasonably low Ct values (&#x0003c;30) in both samples and comment of &#x0201c;A&#x0201d; as a miRNA with a relatively high (&#x0003e;30) Ct value in either the control or test sample and a reasonably low Ct value (&#x0003c;30) in the other sample. Because of inadequate melt curves, <italic>miR&#x02010;3156&#x02010;5p, miR&#x02010;637</italic>, and <italic>miR&#x02010;600</italic> were excluded at this stage, leaving five miRNAs up&#x02010;regulated &#x02265;2&#x02010;fold (Fig. <xref rid="mc22666-fig-0002" ref-type="fig">2</xref>C) and 21 down&#x02010;regulated &#x02265;2&#x02010;fold (Fig. <xref rid="mc22666-fig-0002" ref-type="fig">2</xref>D).</p><p>From the remaining 26 miRNAs, the top three miRNAs showing the greatest fold up&#x02010;regulation and the top four miRNAs showing the greatest fold down&#x02010;regulation were selected for further investigation. These were: <italic>miR&#x02010;135a&#x02010;5p, miR&#x02010;517&#x02010;5p</italic>, and <italic>miR&#x02010;26a&#x02010;1&#x02010;3p</italic> (upregulated genes) and <italic>miR&#x02010;133b, miR&#x02010;640, miR&#x02010;1287&#x02010;5p</italic>, and <italic>miR&#x02010;127&#x02010;3p</italic> (down&#x02010;regulated genes). In addition, <italic>miR&#x02010;32</italic> was selected due to its role in colorectal carcinogenesis.<xref rid="mc22666-bib-0017" ref-type="ref">17</xref>
</p></sec><sec id="mc22666-sec-0018"><label>3.5</label><title>Quantification of miRNA expression in individual participants by qPCR</title><p>qPCR was run using samples from each individual participant in the Control group (<italic>n</italic>&#x02009;=&#x02009;15) and in the RS&#x02009;+&#x02009;PD group (<italic>n</italic>&#x02009;=&#x02009;14) for the eight selected miRNAs. Differences in post&#x02010;intervention miRNA expression were analyzed using the ANOVA GLM. Post&#x02010;intervention expression of <italic>miR&#x02010;32</italic> was approximately threefold greater in participants given RS and PD compared with the Control group (<italic>P</italic>&#x02009;=&#x02009;0.033) (Table <xref rid="mc22666-tbl-0002" ref-type="table-wrap">2</xref>). There were no statistically significant differences in the expression of <italic>miR&#x02010;26a, miR&#x02010;127, miR&#x02010;133b, miR&#x02010;135a, miR&#x02010;517, miR&#x02010;640</italic>, or <italic>miR&#x02010;1287</italic> between the Control and RS&#x02009;+&#x02009;PD groups.</p><table-wrap id="mc22666-tbl-0002" xml:lang="en" orientation="portrait" position="float"><label>Table 2</label><caption><p>Post&#x02010;intervention differences in miRNA expression in DISC Study participants allocated to the control group and to the RS&#x02009;+&#x02009;PD group</p></caption><table frame="below" rules="groups"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><thead valign="bottom"><tr><th align="left" valign="bottom" rowspan="1" colspan="1">MiRNA</th><th align="left" valign="bottom" rowspan="1" colspan="1">Control</th><th align="left" valign="bottom" rowspan="1" colspan="1">RS&#x02009;+&#x02009;PD</th><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic>P</italic>&#x02010;value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">miR&#x02010;26a</td><td align="left" rowspan="1" colspan="1">0.916 (0.281&#x02010;1.000)</td><td align="left" rowspan="1" colspan="1">0.521 (0.521&#x02010;1.421)</td><td align="left" rowspan="1" colspan="1">0.343</td></tr><tr><td align="left" rowspan="1" colspan="1">miR&#x02010;32</td><td align="left" rowspan="1" colspan="1">0.564 (0.343&#x02010;0.926)</td><td align="left" rowspan="1" colspan="1">1.762* (0.980&#x02010;3.168)</td><td align="left" rowspan="1" colspan="1">0.033</td></tr><tr><td align="left" rowspan="1" colspan="1">miR&#x02010;127</td><td align="left" rowspan="1" colspan="1">7.550 (4.140&#x02010;10.960)</td><td align="left" rowspan="1" colspan="1">8.260 (4.497&#x02010;12.023)</td><td align="left" rowspan="1" colspan="1">0.806</td></tr><tr><td align="left" rowspan="1" colspan="1">miR&#x02010;133b</td><td align="left" rowspan="1" colspan="1">0.757 (0.452&#x02010;1.266)</td><td align="left" rowspan="1" colspan="1">1.054 (0.546&#x02010;2.038)</td><td align="left" rowspan="1" colspan="1">0.468</td></tr><tr><td align="left" rowspan="1" colspan="1">miR&#x02010;135a</td><td align="left" rowspan="1" colspan="1">2.963 (1.930&#x02010;4.549)</td><td align="left" rowspan="1" colspan="1">4.375 (2.774&#x02010;6.902)</td><td align="left" rowspan="1" colspan="1">0.285</td></tr><tr><td align="left" rowspan="1" colspan="1">miR&#x02010;517</td><td align="left" rowspan="1" colspan="1">0.888 (0.617&#x02010;1.207)</td><td align="left" rowspan="1" colspan="1">1.147 (0.749&#x02010;1.630)</td><td align="left" rowspan="1" colspan="1">0.372</td></tr><tr><td align="left" rowspan="1" colspan="1">miR&#x02010;640</td><td align="left" rowspan="1" colspan="1">0.429 (0.219&#x02010;0.742)</td><td align="left" rowspan="1" colspan="1">0.402 (0.173&#x02010;0.778)</td><td align="left" rowspan="1" colspan="1">0.902</td></tr><tr><td align="left" rowspan="1" colspan="1">miR&#x02010;1287</td><td align="left" rowspan="1" colspan="1">1.059 (0.411&#x02010;2.733)</td><td align="left" rowspan="1" colspan="1">1.560 (0.576&#x02010;4.228)</td><td align="left" rowspan="1" colspan="1">0.598</td></tr></tbody></table><table-wrap-foot><fn id="mc22666-note-0001"><p>Data are expressed as adjusted copies. Data are presented as least square means (LSMs) and 95% confidence intervals (CIs) are included in parentheses.</p></fn><fn id="mc22666-note-0002"><p>*<italic>P&#x02009;</italic>&#x0003c;&#x02009;0.05 (ANOVA GLM).</p></fn></table-wrap-foot><permissions><copyright-holder>&#x000a9; 2017 Wiley Periodicals, Inc.</copyright-holder></permissions></table-wrap></sec><sec id="mc22666-sec-0019"><label>3.6</label><title>Comparison of PCR array and qPCR of individual participant data</title><p>Quantification of the eight selected miRNAs in individual samples allowed for comparison with the originally obtained PCR array data. For the PCR array data, fold&#x02010;change was calculated for each miRNA by dividing the relative copies (2<sup>&#x02212;&#x00394;Ct</sup>) for the pooled RS&#x02009;+&#x02009;PD group sample by that for the pooled Control group sample. For the individual participant analysis stage, the means of the relative copies for each treatment group were calculated and from this the fold&#x02010;change was estimated. The resulting data are summarized in Table <xref rid="mc22666-tbl-0003" ref-type="table-wrap">3</xref>. The direction of fold&#x02010;change were the same for seven out of eight miRNAs, the exception being <italic>miR&#x02010;133b</italic>, and we observed some differences in the degree of change, for example the magnitude of fold&#x02010;change in <italic>miR&#x02010;135a</italic> for individual participant data was half that observed in the screening array (1.49 vs 3.19).</p><table-wrap id="mc22666-tbl-0003" xml:lang="en" orientation="portrait" position="float"><label>Table 3</label><caption><p>Comparison of fold&#x02010;changes in miRNA expression between control and RS&#x02009;+&#x02009;PD samples using PCR array and subsequent qPCR validation on individual participant samples</p></caption><table frame="below" rules="groups"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><thead valign="bottom"><tr><th align="left" valign="bottom" rowspan="1" colspan="1">MiRNA</th><th align="left" valign="bottom" rowspan="1" colspan="1">Whole miRNome PCR array</th><th align="left" valign="bottom" rowspan="1" colspan="1">qPCR validation</th><th align="left" valign="bottom" rowspan="1" colspan="1">Same fold&#x02010;change direction</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<italic>miR&#x02010;135a</italic>
</td><td align="left" rowspan="1" colspan="1">3.19</td><td align="left" rowspan="1" colspan="1">1.49 (0.26)</td><td align="left" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>miR&#x02010;517</italic>
</td><td align="left" rowspan="1" colspan="1">2.40</td><td align="left" rowspan="1" colspan="1">1.73 (0.59)</td><td align="left" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>miR&#x02010;26a</italic>
</td><td align="left" rowspan="1" colspan="1">2.36</td><td align="left" rowspan="1" colspan="1">1.51 (0.32)</td><td align="left" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>miR&#x02010;32</italic>
</td><td align="left" rowspan="1" colspan="1">&#x02212;1.91</td><td align="left" rowspan="1" colspan="1">&#x02212;1.12 (0.31)</td><td align="left" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>miR&#x02010;127</italic>
</td><td align="left" rowspan="1" colspan="1">&#x02212;3.24</td><td align="left" rowspan="1" colspan="1">&#x02212;1.06 (0.17)</td><td align="left" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>miR&#x02010;1287</italic>
</td><td align="left" rowspan="1" colspan="1">&#x02212;3.55</td><td align="left" rowspan="1" colspan="1">&#x02212;1.05 (0.38)</td><td align="left" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>miR&#x02010;640</italic>
</td><td align="left" rowspan="1" colspan="1">&#x02212;12.21</td><td align="left" rowspan="1" colspan="1">&#x02212;1.12 (0.30)</td><td align="left" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>miR&#x02010;133b</italic>
</td><td align="left" rowspan="1" colspan="1">&#x02212;13.79</td><td align="left" rowspan="1" colspan="1">1.20 (0.44)</td><td align="left" rowspan="1" colspan="1">No</td></tr></tbody></table><table-wrap-foot><fn id="mc22666-note-0003"><p>Data are presented as fold&#x02010;changes (RS&#x02009;+&#x02009;PD group compared with the control group) where data were normalized relative to <italic>RNU&#x02010;6</italic> and <italic>SNORD68</italic>. Data for the qPCR validation were calculated using the mean of all individual samples. SEM are presented in parentheses.</p></fn></table-wrap-foot><permissions><copyright-holder>&#x000a9; 2017 Wiley Periodicals, Inc.</copyright-holder></permissions></table-wrap></sec></sec><sec id="mc22666-sec-0020"><label>4</label><title>DISCUSSION</title><p>miRNAs regulate the expression of thousands of genes by inhibiting their expression and, consequently, have effects on many biological processes including those involved in tumorigenesis.<xref rid="mc22666-bib-0007" ref-type="ref">7</xref>, <xref rid="mc22666-bib-0015" ref-type="ref">15</xref>, <xref rid="mc22666-bib-0018" ref-type="ref">18</xref> Abnormal expression of miRNAs is implicated in the pathogenesis of CRC, where it is associated with disease progression, treatment response, and prognosis.<xref rid="mc22666-bib-0019" ref-type="ref">19</xref>, <xref rid="mc22666-bib-0020" ref-type="ref">20</xref> miRNAs have potential to be used as cancer biomarkers since altered expression is observed not only in colorectal tissue but also in the plasma, stool, and urine from CRC patients.<xref rid="mc22666-bib-0011" ref-type="ref">11</xref>, <xref rid="mc22666-bib-0012" ref-type="ref">12</xref> However, little is known about the potential of miRNAs as early markers of CRC risk and how dietary factors may modulate these markers.</p><p>In the current study, we used a multi&#x02010;step approach to identify miRNAs in the colorectal mucosa of healthy individuals that are potentially regulated by two NDCs (RS and PD). Using a whole miRNome PCR array screen, we first compared the expression of 1008 miRNAs in pooled samples from rectal mucosal biopsies from participants who were randomized to RS&#x02009;+&#x02009;PD or to Control for 50&#x02009;d. The use of pooling techniques has been applied widely in &#x0201c;omics&#x0201d; studies including those analyzing miRNA expression<xref rid="mc22666-bib-0021" ref-type="ref">21</xref>, <xref rid="mc22666-bib-0022" ref-type="ref">22</xref>, <xref rid="mc22666-bib-0023" ref-type="ref">23</xref> and is particularly valuable when samples are precious or limited.<xref rid="mc22666-bib-0024" ref-type="ref">24</xref> This screening stage revealed 33 miRNAs that were up&#x02010;regulated and 78 miRNAs that were down&#x02010;regulated by &#x02265;2&#x02010;fold in the RS&#x02009;+&#x02009;PD group compared with the Control group. From these, eight miRNAs (<italic>miR&#x02010;26a, miR&#x02010;21, miR&#x02010;133b, miR&#x02010;135a, miR&#x02010;517, miR&#x02010;640</italic> and <italic>miR&#x02010;1287</italic>, and <italic>miR&#x02010;32</italic>) were selected for validation in individual participant samples. Validation by qPCR revealed consistent fold&#x02010;change direction for seven of the eight miRNAs. A possible explanation for the inconsistency observed for <italic>miR&#x02010;133b</italic> is the increased chance of error associated with the PCR array, whereas qPCR analysis of individual participant samples provides a more reliable and robust method with reduced chance of error, especially as all analyses were performed in duplicate. Fold&#x02010;changes were lower in the qPCR data compared with the array data and we expect that this resulted from differences in miRNA abundance in the pooled samples, which may not have been mathematically equivalent to the mean of the abundances in individual participant samples.</p><p>Post&#x02010;intervention, <italic>miR&#x02010;32</italic> expression was approximately threefold greater in participants supplemented with RS&#x02009;+&#x02009;PD compared with the Control (<italic>P</italic>&#x02009;=&#x02009;0.033). At first sight, our findings are surprising as <italic>miR&#x02010;32</italic> expression has been found to be up&#x02010;regulated in colon tumor tissue compared with normal tissue and increased with advancing tumor stage.<xref rid="mc22666-bib-0025" ref-type="ref">25</xref>
<italic>miR&#x02010;32</italic> has been shown to promote proliferation, migration, and invasion in colorectal and gastric cancer cells and reduces apoptosis.<xref rid="mc22666-bib-0017" ref-type="ref">17</xref>, <xref rid="mc22666-bib-0026" ref-type="ref">26</xref>, <xref rid="mc22666-bib-0027" ref-type="ref">27</xref> There also appears to be a connection between <italic>miR&#x02010;32</italic> and inflammation via the regulation of tumor necrosis factor receptor&#x02010;associated factor&#x02010;3 (<italic>TRAF3</italic>), an activator of the non&#x02010;canonical NF&#x02010;&#x003ba;B pathway.<xref rid="mc22666-bib-0028" ref-type="ref">28</xref> Therefore, downregulation of <italic>TRAF3</italic> by <italic>miR&#x02010;32</italic> could lead to increased inflammation and effects on other processes such as cell proliferation and cell death through stimulated NF&#x02010;&#x003ba;B signaling.<xref rid="mc22666-bib-0029" ref-type="ref">29</xref>, <xref rid="mc22666-bib-0030" ref-type="ref">30</xref>, <xref rid="mc22666-bib-0031" ref-type="ref">31</xref>
</p><p>While our findings are contradictory to evidence supporting butyrate's anti&#x02010;inflammatory properties, it is possible that effects on <italic>miR&#x02010;32</italic> expression and consequently on the NF&#x02010;&#x003ba;B non&#x02010;canonical pathway could be one of the mechanisms via which NDCs modulate processes such as cell proliferation and apoptosis.<xref rid="mc22666-bib-0005" ref-type="ref">5</xref> The very limited research on the effects of NDCs on miRNA expression in the large bowel mucosa suggests that RS and butyrate may reduce the expression of oncogenic miRNAs.<xref rid="mc22666-bib-0014" ref-type="ref">14</xref>, <xref rid="mc22666-bib-0015" ref-type="ref">15</xref> To our knowledge, our study is the first to report the effects of NDC supplementation on <italic>miR&#x02010;32</italic> expression in the human colorectal epithelium. The observed increase in <italic>miR&#x02010;32</italic> expression could be one of the mechanisms through which, in healthy colorectal cells, butyrate stimulates cell proliferation.<xref rid="mc22666-bib-0032" ref-type="ref">32</xref>, <xref rid="mc22666-bib-0033" ref-type="ref">33</xref>, <xref rid="mc22666-bib-0034" ref-type="ref">34</xref> In contrast, NDCs and butyrate reduce cell proliferation and promote apoptosis in CRC cells,<xref rid="mc22666-bib-0035" ref-type="ref">35</xref>, <xref rid="mc22666-bib-0036" ref-type="ref">36</xref>, <xref rid="mc22666-bib-0037" ref-type="ref">37</xref>, <xref rid="mc22666-bib-0038" ref-type="ref">38</xref>, <xref rid="mc22666-bib-0039" ref-type="ref">39</xref> referred to as the butyrate paradox,<xref rid="mc22666-bib-0040" ref-type="ref">40</xref> and the role of miRNAs in mediating these phenomena in both healthy and cancer tissue deserves further investigation.</p><p>Although, we did not observe significant effects of NDCs on expression of the additional seven miRNAs quantified, further investigation of possible effects of NDCs and other dietary factors on these miRNA in larger studies is warranted. We observed considerable inter&#x02010;individual variation in response to supplementation (evidenced by relatively large SEM values&#x02014;Table <xref rid="mc22666-tbl-0003" ref-type="table-wrap">3</xref>) so that despite mean differences of up to 50%, these were not statistically significant. Furthermore, some of these miRNAs may have potential for development as biomarkers in investigations of the protective or detrimental effects of dietary factors, such as red meat and dietary fibre, on CRC risk. For example, <italic>miR&#x02010;1287</italic>
<xref rid="mc22666-bib-0041" ref-type="ref">41</xref> and <italic>miR&#x02010;517</italic>
<xref rid="mc22666-bib-0042" ref-type="ref">42</xref> are upregulated in CRC tissue and <italic>miR&#x02010;133b</italic> (which has been proposed to be a tumor suppressor) is downregulated in SW&#x02010;620 and HT&#x02010;29 colon cells.<xref rid="mc22666-bib-0043" ref-type="ref">43</xref> In addition, <italic>miR&#x02010;135a</italic> has been identified as a biomarker of CRC in serum<xref rid="mc22666-bib-0044" ref-type="ref">44</xref> and was downregulated by butyrate and trichostatin A, another HDACi, in LT97 colon adenoma cells. This effect was associated with reduced cell proliferation, suggesting that <italic>miR&#x02010;135a</italic> may be involved in butyrate&#x02010;mediated inhibition of cell proliferation in CRC cells.<xref rid="mc22666-bib-0008" ref-type="ref">8</xref>
</p><p>This study is the first to use a multi&#x02010;step approach to identify miRNAs in the colorectal mucosa of healthy individuals that are regulated by RS and PD. Participants in the study had been shown at endoscopy to have a normal colon and rectum and supplementation using a randomized double&#x02010;blind design ensured that observed effects are likely to be causal. This study has shown that <italic>miR&#x02010;32</italic> expression in the colorectal mucosa of healthy human participants increased substantially after supplementation with RS&#x02009;+&#x02009;PD for 50&#x02009;d. Given the potential roles of this miRNA in regulation of the cell cycle, inflammation, and interactions with the gut microbiota, further studies are warranted to confirm our findings and to investigate the utility of <italic>miR&#x02010;32</italic> as a diet&#x02010;responsive biomarker of gut health. The findings from this RCT study, although relatively small, provide valuable evidence of causality which is free from confounding issues associated with observational studies, such as the subjectivity of self&#x02010;reported dietary data.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material content-type="local-data"><p>Additional Supporting Information may be found online in the supporting information tab for this article.</p></supplementary-material><supplementary-material content-type="local-data"><caption><p>Additional File 2.</p></caption><media xlink:href="MC-56-2104-s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack id="mc22666-sec-0021"><title>ACKNOWLEDGMENTS</title><p>We acknowledge the staff at the gastroenterology units at Wansbeck and North Tyneside General Hospitals for their help and support. We also thank the DISC Study participants without whom this study would have been impossible.</p></ack><ref-list id="mc22666-bibl-0001" content-type="cited-references"><title>REFERENCES</title><ref id="mc22666-bib-0001"><label>1</label><mixed-citation publication-type="miscellaneous" id="mc22666-cit-0001">CRUK. Cancer Research UK bowel cancer incidence statistics. 2014. Available online at: <ext-link ext-link-type="uri" xlink:href="http://www.cancerresearchuk.org/cancer-info/cancerstats/types/bowel/incidence/">http://www.cancerresearchuk.org/cancer-info/cancerstats/types/bowel/incidence/</ext-link> Accessed 2nd September 2014.
</mixed-citation></ref><ref id="mc22666-bib-0002"><label>2</label><mixed-citation publication-type="miscellaneous" id="mc22666-cit-0002">WCRF/AICR. World Cancer Research Fund/American Institute for Cancer Research. Continuous update project report. Food, nutrition, physical activity, and the prevention of colorectal cancer 2011. 2011.
</mixed-citation></ref><ref id="mc22666-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="mc22666-cit-0003">
<string-name>
<surname>Pryde</surname>
<given-names>SE</given-names>
</string-name>, 
<string-name>
<surname>Duncan</surname>
<given-names>SH</given-names>
</string-name>, 
<string-name>
<surname>Hold</surname>
<given-names>GL</given-names>
</string-name>, 
<string-name>
<surname>Stewart</surname>
<given-names>CS</given-names>
</string-name>, 
<string-name>
<surname>Flint</surname>
<given-names>HJ</given-names>
</string-name>. <article-title>The microbiology of butyrate formation in the human colon</article-title>. 
<source>FEMS Microbiol Lett</source>. 
<year>2002</year>;
<volume>217</volume>:<fpage>133</fpage>&#x02013;<lpage>139</lpage>.
<pub-id pub-id-type="pmid">12480096</pub-id></mixed-citation></ref><ref id="mc22666-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="mc22666-cit-0004">
<string-name>
<surname>Louis</surname>
<given-names>P</given-names>
</string-name>, 
<string-name>
<surname>Hold</surname>
<given-names>GL</given-names>
</string-name>, 
<string-name>
<surname>Flint</surname>
<given-names>HJ</given-names>
</string-name>. <article-title>The gut microbiota, bacterial metabolites and colorectal cancer</article-title>. 
<source>Nat Rev Microbiol</source>. 
<year>2014</year>;
<volume>12</volume>:<fpage>661</fpage>&#x02013;<lpage>672</lpage>.
<pub-id pub-id-type="pmid">25198138</pub-id></mixed-citation></ref><ref id="mc22666-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="mc22666-cit-0005">
<string-name>
<surname>Nofrarias</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Martinez&#x02010;Puig</surname>
<given-names>D</given-names>
</string-name>, 
<string-name>
<surname>Pujols</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Majo</surname>
<given-names>N</given-names>
</string-name>, 
<string-name>
<surname>Perez</surname>
<given-names>JF</given-names>
</string-name>. <article-title>Long&#x02010;term intake of resistant starch improves colonic mucosal integrity and reduces gut apoptosis and blood immune cells</article-title>. 
<source>Nutrition</source>. 
<year>2007</year>;
<volume>23</volume>:<fpage>861</fpage>&#x02013;<lpage>870</lpage>.
<pub-id pub-id-type="pmid">17936196</pub-id></mixed-citation></ref><ref id="mc22666-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="mc22666-cit-0006">
<string-name>
<surname>Fung</surname>
<given-names>KY</given-names>
</string-name>, 
<string-name>
<surname>Cosgrove</surname>
<given-names>L</given-names>
</string-name>, 
<string-name>
<surname>Lockett</surname>
<given-names>T</given-names>
</string-name>, 
<string-name>
<surname>Head</surname>
<given-names>R</given-names>
</string-name>, 
<string-name>
<surname>Topping</surname>
<given-names>DL</given-names>
</string-name>. <article-title>A review of the potential mechanisms for the lowering of colorectal oncogenesis by butyrate</article-title>. 
<source>Br J Nutr</source>. 
<year>2012</year>;
<volume>108</volume>:<fpage>820</fpage>&#x02013;<lpage>831</lpage>.
<pub-id pub-id-type="pmid">22676885</pub-id></mixed-citation></ref><ref id="mc22666-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="mc22666-cit-0007">
<string-name>
<surname>Hu</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Dong</surname>
<given-names>TS</given-names>
</string-name>, 
<string-name>
<surname>Dalal</surname>
<given-names>SR</given-names>
</string-name>, et al. <article-title>The microbe&#x02010;derived short chain fatty acid butyrate targets miRNA&#x02010;dependent p21 gene expression in human colon cancer</article-title>. 
<source>PLoS ONE</source>. 
<year>2011</year>;
<volume>6</volume>:<fpage>e16221</fpage>.
<pub-id pub-id-type="pmid">21283757</pub-id></mixed-citation></ref><ref id="mc22666-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="mc22666-cit-0008">
<string-name>
<surname>Schlormann</surname>
<given-names>W</given-names>
</string-name>, 
<string-name>
<surname>Naumann</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Renner</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Glei</surname>
<given-names>M</given-names>
</string-name>. <article-title>Influence of miRNA&#x02010;106b and miRNA&#x02010;135a on butyrate&#x02010;regulated expression of p21 and Cyclin D2 in human colon adenoma cells</article-title>. 
<source>Genes Nutr</source>. 
<year>2015</year>;
<volume>10</volume>:<fpage>50</fpage>.
<pub-id pub-id-type="pmid">26559563</pub-id></mixed-citation></ref><ref id="mc22666-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="mc22666-cit-0009">
<string-name>
<surname>Song</surname>
<given-names>JH</given-names>
</string-name>, 
<string-name>
<surname>Meltzer</surname>
<given-names>SJ</given-names>
</string-name>. <article-title>MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers</article-title>. 
<source>Gastroenterology</source>. 
<year>2012</year>;
<volume>143</volume>:<fpage>35</fpage>&#x02013;<lpage>47</lpage>. e32.
<pub-id pub-id-type="pmid">22580099</pub-id></mixed-citation></ref><ref id="mc22666-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="mc22666-cit-0010">
<string-name>
<surname>Lewis</surname>
<given-names>BP</given-names>
</string-name>, 
<string-name>
<surname>Burge</surname>
<given-names>CB</given-names>
</string-name>, 
<string-name>
<surname>Bartel</surname>
<given-names>DP</given-names>
</string-name>. <article-title>Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets</article-title>. 
<source>Cell</source>. 
<year>2005</year>;
<volume>120</volume>:<fpage>15</fpage>&#x02013;<lpage>20</lpage>.
<pub-id pub-id-type="pmid">15652477</pub-id></mixed-citation></ref><ref id="mc22666-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="mc22666-cit-0011">
<string-name>
<surname>Wu</surname>
<given-names>CW</given-names>
</string-name>, 
<string-name>
<surname>Ng</surname>
<given-names>SS</given-names>
</string-name>, 
<string-name>
<surname>Dong</surname>
<given-names>YJ</given-names>
</string-name>, et al. <article-title>Detection of miR&#x02010;92a and miR&#x02010;21 in stool samples as potential screening biomarkers for colorectal cancer and polyps</article-title>. 
<source>Gut</source>. 
<year>2012</year>;
<volume>61</volume>:<fpage>739</fpage>&#x02013;<lpage>745</lpage>.
<pub-id pub-id-type="pmid">21930727</pub-id></mixed-citation></ref><ref id="mc22666-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="mc22666-cit-0012">
<string-name>
<surname>Wang</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Xiang</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Li</surname>
<given-names>Z</given-names>
</string-name>, et al. <article-title>A plasma microRNA panel for early detection of colorectal cancer</article-title>. 
<source>Int J Cancer</source>. 
<year>2015</year>;
<volume>136</volume>:<fpage>152</fpage>&#x02013;<lpage>161</lpage>.
<pub-id pub-id-type="pmid">23456911</pub-id></mixed-citation></ref><ref id="mc22666-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="mc22666-cit-0013">
<string-name>
<surname>Slattery</surname>
<given-names>ML</given-names>
</string-name>, 
<string-name>
<surname>Herrick</surname>
<given-names>JS</given-names>
</string-name>, 
<string-name>
<surname>Mullany</surname>
<given-names>LE</given-names>
</string-name>, 
<string-name>
<surname>Stevens</surname>
<given-names>JR</given-names>
</string-name>, 
<string-name>
<surname>Wolff</surname>
<given-names>RK</given-names>
</string-name>. <article-title>Diet and lifestyle factors associated with miRNA expression in colorectal tissue</article-title>. 
<source>Pharmgenomics Pers Med</source>. 
<year>2017</year>;
<volume>10</volume>:<fpage>1</fpage>&#x02013;<lpage>16</lpage>.
<pub-id pub-id-type="pmid">28053552</pub-id></mixed-citation></ref><ref id="mc22666-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="mc22666-cit-0014">
<string-name>
<surname>Humphreys</surname>
<given-names>KJ</given-names>
</string-name>, 
<string-name>
<surname>Cobiac</surname>
<given-names>L</given-names>
</string-name>, 
<string-name>
<surname>Le Leu</surname>
<given-names>RK</given-names>
</string-name>, 
<string-name>
<surname>Van der Hoek</surname>
<given-names>MB</given-names>
</string-name>, 
<string-name>
<surname>Michael</surname>
<given-names>MZ</given-names>
</string-name>. <article-title>Histone deacetylase inhibition in colorectal cancer cells reveals competing roles for members of the oncogenic miR&#x02010;17&#x02010;92 cluster</article-title>. 
<source>Mol Carcinog</source>. 
<year>2013</year>;
<volume>52</volume>:<fpage>459</fpage>&#x02013;<lpage>474</lpage>.
<pub-id pub-id-type="pmid">22308110</pub-id></mixed-citation></ref><ref id="mc22666-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="mc22666-cit-0015">
<string-name>
<surname>Humphreys</surname>
<given-names>KJ</given-names>
</string-name>, 
<string-name>
<surname>Conlon</surname>
<given-names>MA</given-names>
</string-name>, 
<string-name>
<surname>Young</surname>
<given-names>GP</given-names>
</string-name>, et al. <article-title>Dietary manipulation of oncogenic MicroRNA expression in human rectal mucosa: A randomized trial</article-title>. 
<source>Cancer Prev Res (Phila)</source>. 
<year>2014</year>;
<volume>7</volume>:<fpage>786</fpage>&#x02013;<lpage>795</lpage>.
<pub-id pub-id-type="pmid">25092886</pub-id></mixed-citation></ref><ref id="mc22666-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="mc22666-cit-0016">
<string-name>
<surname>Malcomson</surname>
<given-names>FC</given-names>
</string-name>, 
<string-name>
<surname>Willis</surname>
<given-names>ND</given-names>
</string-name>, 
<string-name>
<surname>McCallum</surname>
<given-names>I</given-names>
</string-name>, et al. <article-title>Effects of supplementation with nondigestible carbohydrates on fecal calprotectin and on epigenetic regulation of SFRP1 expression in the large&#x02010;bowel mucosa of healthy individuals</article-title>. 
<source>Am J Clin Nutr</source>. 
<year>2017</year>;
<volume>105</volume>:<fpage>400</fpage>&#x02013;<lpage>410</lpage>.
<pub-id pub-id-type="pmid">28077379</pub-id></mixed-citation></ref><ref id="mc22666-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="mc22666-cit-0017">
<string-name>
<surname>Wu</surname>
<given-names>W</given-names>
</string-name>, 
<string-name>
<surname>Yang</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Feng</surname>
<given-names>X</given-names>
</string-name>, et al. <article-title>MicroRNA&#x02010;32 (miR&#x02010;32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells</article-title>. 
<source>Mol Cancer</source>. 
<year>2013</year>;
<volume>12</volume>:<fpage>30</fpage>.
<pub-id pub-id-type="pmid">23617834</pub-id></mixed-citation></ref><ref id="mc22666-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="mc22666-cit-0018">
<string-name>
<surname>Hu</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Liu</surname>
<given-names>L</given-names>
</string-name>, 
<string-name>
<surname>Chang</surname>
<given-names>EB</given-names>
</string-name>, 
<string-name>
<surname>Wang</surname>
<given-names>JY</given-names>
</string-name>, 
<string-name>
<surname>Raufman</surname>
<given-names>JP</given-names>
</string-name>. <article-title>Butyrate inhibits pro&#x02010;proliferative miR&#x02010;92a by diminishing c&#x02010;Myc&#x02010;induced miR&#x02010;17&#x02010;92a cluster transcription in human colon cancer cells</article-title>. 
<source>Mol Cancer</source>. 
<year>2015</year>;
<volume>14</volume>:<fpage>180</fpage>.
<pub-id pub-id-type="pmid">26463716</pub-id></mixed-citation></ref><ref id="mc22666-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="mc22666-cit-0019">
<string-name>
<surname>Diosdado</surname>
<given-names>B</given-names>
</string-name>, 
<string-name>
<surname>van de Wiel</surname>
<given-names>MA</given-names>
</string-name>, 
<string-name>
<surname>Terhaar Sive Droste</surname>
<given-names>JS</given-names>
</string-name>, et al. <article-title>MiR&#x02010;17&#x02010;92 cluster is associated with 13q gain and c&#x02010;myc expression during colorectal adenoma to adenocarcinoma progression</article-title>. 
<source>Br J Cancer</source>. 
<year>2009</year>;
<volume>101</volume>:<fpage>707</fpage>&#x02013;<lpage>714</lpage>.
<pub-id pub-id-type="pmid">19672269</pub-id></mixed-citation></ref><ref id="mc22666-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="mc22666-cit-0020">
<string-name>
<surname>Slaby</surname>
<given-names>O</given-names>
</string-name>, 
<string-name>
<surname>Svoboda</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Fabian</surname>
<given-names>P</given-names>
</string-name>, et al. <article-title>Altered expression of miR&#x02010;21, miR&#x02010;31, miR&#x02010;143 and miR&#x02010;145 is related to clinicopathologic features of colorectal cancer</article-title>. 
<source>Oncology</source>. 
<year>2007</year>;
<volume>72</volume>:<fpage>397</fpage>&#x02013;<lpage>402</lpage>.
<pub-id pub-id-type="pmid">18196926</pub-id></mixed-citation></ref><ref id="mc22666-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="mc22666-cit-0021">
<string-name>
<surname>Kendziorski</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Irizarry</surname>
<given-names>RA</given-names>
</string-name>, 
<string-name>
<surname>Chen</surname>
<given-names>KS</given-names>
</string-name>, 
<string-name>
<surname>Haag</surname>
<given-names>JD</given-names>
</string-name>, 
<string-name>
<surname>Gould</surname>
<given-names>MN</given-names>
</string-name>. <article-title>On the utility of pooling biological samples in microarray experiments</article-title>. 
<source>Proc Natl Acad Sci USA</source>. 
<year>2005</year>;
<volume>102</volume>:<fpage>4252</fpage>&#x02013;<lpage>4257</lpage>.
<pub-id pub-id-type="pmid">15755808</pub-id></mixed-citation></ref><ref id="mc22666-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="mc22666-cit-0022">
<string-name>
<surname>Pescador</surname>
<given-names>N</given-names>
</string-name>, 
<string-name>
<surname>Perez&#x02010;Barba</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Ibarra</surname>
<given-names>JM</given-names>
</string-name>, 
<string-name>
<surname>Corbaton</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Martinez&#x02010;Larrad</surname>
<given-names>MT</given-names>
</string-name>, 
<string-name>
<surname>Serrano&#x02010;Rios</surname>
<given-names>M</given-names>
</string-name>. <article-title>Serum circulating microRNA profiling for identification of potential type 2 diabetes and obesity biomarkers</article-title>. 
<source>PLoS ONE</source>. 
<year>2013</year>;
<volume>8</volume>:<fpage>e77251</fpage>.
<pub-id pub-id-type="pmid">24204780</pub-id></mixed-citation></ref><ref id="mc22666-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="mc22666-cit-0023">
<string-name>
<surname>Aherne</surname>
<given-names>ST</given-names>
</string-name>, 
<string-name>
<surname>Madden</surname>
<given-names>SF</given-names>
</string-name>, 
<string-name>
<surname>Hughes</surname>
<given-names>DJ</given-names>
</string-name>, et al. <article-title>Circulating miRNAs miR&#x02010;34a and miR&#x02010;150 associated with colorectal cancer progression</article-title>. 
<source>BMC Cancer</source>. 
<year>2015</year>;
<volume>15</volume>:<fpage>329</fpage>.
<pub-id pub-id-type="pmid">25924769</pub-id></mixed-citation></ref><ref id="mc22666-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="mc22666-cit-0024">
<string-name>
<surname>Wu</surname>
<given-names>W</given-names>
</string-name>, 
<string-name>
<surname>Qin</surname>
<given-names>Y</given-names>
</string-name>, 
<string-name>
<surname>Li</surname>
<given-names>Z</given-names>
</string-name>, et al. <article-title>Genome&#x02010;wide microRNA expression profiling in idiopathic non&#x02010;obstructive azoospermia: Significant up&#x02010;regulation of miR&#x02010;141, miR&#x02010;429 and miR&#x02010;7&#x02010;1&#x02010;3p</article-title>. 
<source>Hum Reprod</source>. 
<year>2013</year>;
<volume>28</volume>:<fpage>1827</fpage>&#x02013;<lpage>1836</lpage>.
<pub-id pub-id-type="pmid">23559187</pub-id></mixed-citation></ref><ref id="mc22666-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="mc22666-cit-0025">
<string-name>
<surname>Sarver</surname>
<given-names>AL</given-names>
</string-name>, 
<string-name>
<surname>French</surname>
<given-names>AJ</given-names>
</string-name>, 
<string-name>
<surname>Borralho</surname>
<given-names>PM</given-names>
</string-name>, et al. <article-title>Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states</article-title>. 
<source>BMC Cancer</source>. 
<year>2009</year>;
<volume>9</volume>:<fpage>401</fpage>.
<pub-id pub-id-type="pmid">19922656</pub-id></mixed-citation></ref><ref id="mc22666-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="mc22666-cit-0026">
<string-name>
<surname>Yan</surname>
<given-names>SY</given-names>
</string-name>, 
<string-name>
<surname>Chen</surname>
<given-names>MM</given-names>
</string-name>, 
<string-name>
<surname>Li</surname>
<given-names>GM</given-names>
</string-name>, 
<string-name>
<surname>Wang</surname>
<given-names>YQ</given-names>
</string-name>, 
<string-name>
<surname>Fan</surname>
<given-names>JG</given-names>
</string-name>. <article-title>MiR&#x02010;32 induces cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting PTEN</article-title>. 
<source>Tumour Biol</source>. 
<year>2015</year>;
<volume>36</volume>:<fpage>4747</fpage>&#x02013;<lpage>4755</lpage>.
<pub-id pub-id-type="pmid">25647261</pub-id></mixed-citation></ref><ref id="mc22666-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="mc22666-cit-0027">
<string-name>
<surname>Yan</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Yu</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Liu</surname>
<given-names>Y</given-names>
</string-name>, 
<string-name>
<surname>Kang</surname>
<given-names>W</given-names>
</string-name>, 
<string-name>
<surname>Ma</surname>
<given-names>Z</given-names>
</string-name>, 
<string-name>
<surname>Zhou</surname>
<given-names>L</given-names>
</string-name>. <article-title>MiR&#x02010;32 promotes gastric carcinoma tumorigenesis by targeting Kruppel&#x02010;like factor 4</article-title>. 
<source>Biochem Biophys Res Commun</source>. 
<year>2015</year>;
<volume>467</volume>:<fpage>913</fpage>&#x02013;<lpage>920</lpage>.
<pub-id pub-id-type="pmid">26471298</pub-id></mixed-citation></ref><ref id="mc22666-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="mc22666-cit-0028">
<string-name>
<surname>Mishra</surname>
<given-names>R</given-names>
</string-name>, 
<string-name>
<surname>Chhatbar</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Singh</surname>
<given-names>SK</given-names>
</string-name>. <article-title>HIV&#x02010;1 Tat C&#x02010;mediated regulation of tumor necrosis factor receptor&#x02010;associated factor&#x02010;3 by microRNA 32 in human microglia</article-title>. 
<source>J Neuroinflammation</source>. 
<year>2012</year>;
<volume>9</volume>:<fpage>131</fpage>.
<pub-id pub-id-type="pmid">22709905</pub-id></mixed-citation></ref><ref id="mc22666-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="mc22666-cit-0029">
<string-name>
<surname>Allen</surname>
<given-names>IC</given-names>
</string-name>, 
<string-name>
<surname>Wilson</surname>
<given-names>JE</given-names>
</string-name>, 
<string-name>
<surname>Schneider</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF&#x02010;kappaB signaling</article-title>. 
<source>Immunity</source>. 
<year>2012</year>;
<volume>36</volume>:<fpage>742</fpage>&#x02013;<lpage>754</lpage>.
<pub-id pub-id-type="pmid">22503542</pub-id></mixed-citation></ref><ref id="mc22666-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="mc22666-cit-0030">
<string-name>
<surname>Zarnegar</surname>
<given-names>BJ</given-names>
</string-name>, 
<string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, 
<string-name>
<surname>Mahoney</surname>
<given-names>DJ</given-names>
</string-name>, et al. <article-title>Noncanonical NF&#x02010;kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK</article-title>. 
<source>Nat Immunol</source>. 
<year>2008</year>;
<volume>9</volume>:<fpage>1371</fpage>&#x02013;<lpage>1378</lpage>.
<pub-id pub-id-type="pmid">18997794</pub-id></mixed-citation></ref><ref id="mc22666-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="mc22666-cit-0031">
<string-name>
<surname>Vaiopoulos</surname>
<given-names>AG</given-names>
</string-name>, 
<string-name>
<surname>Athanasoula</surname>
<given-names>K</given-names>
</string-name>, 
<string-name>
<surname>Papavassiliou</surname>
<given-names>AG</given-names>
</string-name>. <article-title>NF&#x02010;kappaB in colorectal cancer</article-title>. 
<source>J Mol Med (Berl)</source>. 
<year>2013</year>;
<volume>91</volume>:<fpage>1029</fpage>&#x02013;<lpage>1037</lpage>.
<pub-id pub-id-type="pmid">23636511</pub-id></mixed-citation></ref><ref id="mc22666-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="mc22666-cit-0032">
<string-name>
<surname>Kien</surname>
<given-names>CL</given-names>
</string-name>, 
<string-name>
<surname>Blauwiekel</surname>
<given-names>R</given-names>
</string-name>, 
<string-name>
<surname>Bunn</surname>
<given-names>JY</given-names>
</string-name>, 
<string-name>
<surname>Jetton</surname>
<given-names>TL</given-names>
</string-name>, 
<string-name>
<surname>Frankel</surname>
<given-names>WL</given-names>
</string-name>, 
<string-name>
<surname>Holst</surname>
<given-names>JJ</given-names>
</string-name>. <article-title>Cecal infusion of butyrate increases intestinal cell proliferation in piglets</article-title>. 
<source>J Nutr</source>. 
<year>2007</year>;
<volume>137</volume>:<fpage>916</fpage>&#x02013;<lpage>922</lpage>.
<pub-id pub-id-type="pmid">17374654</pub-id></mixed-citation></ref><ref id="mc22666-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="mc22666-cit-0033">
<string-name>
<surname>Mortensen</surname>
<given-names>FV</given-names>
</string-name>, 
<string-name>
<surname>Langkilde</surname>
<given-names>NC</given-names>
</string-name>, 
<string-name>
<surname>Joergensen</surname>
<given-names>JC</given-names>
</string-name>, 
<string-name>
<surname>Hessov</surname>
<given-names>I</given-names>
</string-name>. <article-title>Short&#x02010;chain fatty acids stimulate mucosal cell proliferation in the closed human rectum after Hartmann's procedure</article-title>. 
<source>Int J Colorectal Dis</source>. 
<year>1999</year>;
<volume>14</volume>:<fpage>150</fpage>&#x02013;<lpage>154</lpage>.
<pub-id pub-id-type="pmid">10460905</pub-id></mixed-citation></ref><ref id="mc22666-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="mc22666-cit-0034">
<string-name>
<surname>Scheppach</surname>
<given-names>W</given-names>
</string-name>, 
<string-name>
<surname>Bartram</surname>
<given-names>P</given-names>
</string-name>, 
<string-name>
<surname>Richter</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Effect of short&#x02010;chain fatty acids on the human colonic mucosa in vitro</article-title>. 
<source>JPEN J Parenter Enteral Nutr</source>. 
<year>1992</year>;
<volume>16</volume>:<fpage>43</fpage>&#x02013;<lpage>48</lpage>.
<pub-id pub-id-type="pmid">1738218</pub-id></mixed-citation></ref><ref id="mc22666-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="mc22666-cit-0035">
<string-name>
<surname>Dronamraju</surname>
<given-names>SS</given-names>
</string-name>, 
<string-name>
<surname>Coxhead</surname>
<given-names>JM</given-names>
</string-name>, 
<string-name>
<surname>Kelly</surname>
<given-names>SB</given-names>
</string-name>, 
<string-name>
<surname>Burn</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Mathers</surname>
<given-names>JC</given-names>
</string-name>. <article-title>Cell kinetics and gene expression changes in colorectal cancer patients given resistant starch: A randomised controlled trial</article-title>. 
<source>Gut</source>. 
<year>2009</year>;
<volume>58</volume>:<fpage>413</fpage>&#x02013;<lpage>420</lpage>.
<pub-id pub-id-type="pmid">18978177</pub-id></mixed-citation></ref><ref id="mc22666-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="mc22666-cit-0036">
<string-name>
<surname>Purwani</surname>
<given-names>E</given-names>
</string-name>, 
<string-name>
<surname>Iskandriati</surname>
<given-names>D</given-names>
</string-name>, 
<string-name>
<surname>Suhartono</surname>
<given-names>M</given-names>
</string-name>. <article-title>Fermentation product of RS3 inhibited proliferation and induced apoptosis in colon cancer cell HCT&#x02010;116</article-title>. 
<source>Advances in Bioscience and Biotechnology</source>. 
<year>2012</year>;
<volume>3</volume>:<fpage>1189</fpage>&#x02013;<lpage>1198</lpage>.
</mixed-citation></ref><ref id="mc22666-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="mc22666-cit-0037">
<string-name>
<surname>Ruemmele</surname>
<given-names>FM</given-names>
</string-name>, 
<string-name>
<surname>Dionne</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Qureshi</surname>
<given-names>I</given-names>
</string-name>, 
<string-name>
<surname>Sarma</surname>
<given-names>DS</given-names>
</string-name>, 
<string-name>
<surname>Levy</surname>
<given-names>E</given-names>
</string-name>, 
<string-name>
<surname>Seidman</surname>
<given-names>EG</given-names>
</string-name>. <article-title>Butyrate mediates Caco&#x02010;2 cell apoptosis via up&#x02010;regulation of pro&#x02010;apoptotic BAK and inducing caspase&#x02010;3 mediated cleavage of poly&#x02010;(ADP&#x02010;ribose) polymerase (PARP)</article-title>. 
<source>Cell Death Differ</source>. 
<year>1999</year>;
<volume>6</volume>:<fpage>729</fpage>&#x02013;<lpage>735</lpage>.
<pub-id pub-id-type="pmid">10467346</pub-id></mixed-citation></ref><ref id="mc22666-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="mc22666-cit-0038">
<string-name>
<surname>Le Leu</surname>
<given-names>RK</given-names>
</string-name>, 
<string-name>
<surname>Brown</surname>
<given-names>IL</given-names>
</string-name>, 
<string-name>
<surname>Hu</surname>
<given-names>Y</given-names>
</string-name>, 
<string-name>
<surname>Esterman</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Young</surname>
<given-names>GP</given-names>
</string-name>. <article-title>Suppression of azoxymethane&#x02010;induced colon cancer development in rats by dietary resistant starch</article-title>. 
<source>Cancer Biol Ther</source>. 
<year>2007</year>;
<volume>6</volume>:<fpage>1621</fpage>&#x02013;<lpage>1626</lpage>.
<pub-id pub-id-type="pmid">17932462</pub-id></mixed-citation></ref><ref id="mc22666-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="mc22666-cit-0039">
<string-name>
<surname>Bauer&#x02010;Marinovic</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Florian</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Muller&#x02010;Schmehl</surname>
<given-names>K</given-names>
</string-name>, 
<string-name>
<surname>Glatt</surname>
<given-names>H</given-names>
</string-name>, 
<string-name>
<surname>Jacobasch</surname>
<given-names>G</given-names>
</string-name>. <article-title>Dietary resistant starch type 3 prevents tumor induction by 1, 2&#x02010;dimethylhydrazine and alters proliferation, apoptosis and dedifferentiation in rat colon</article-title>. 
<source>Carcinogenesis</source>. 
<year>2006</year>;
<volume>27</volume>:<fpage>1849</fpage>&#x02013;<lpage>1859</lpage>.
<pub-id pub-id-type="pmid">16597648</pub-id></mixed-citation></ref><ref id="mc22666-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="mc22666-cit-0040">
<string-name>
<surname>Donohoe</surname>
<given-names>DR</given-names>
</string-name>, 
<string-name>
<surname>Collins</surname>
<given-names>LB</given-names>
</string-name>, 
<string-name>
<surname>Wali</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Bigler</surname>
<given-names>R</given-names>
</string-name>, 
<string-name>
<surname>Sun</surname>
<given-names>W</given-names>
</string-name>, 
<string-name>
<surname>Bultman</surname>
<given-names>SJ</given-names>
</string-name>. <article-title>The Warburg effect dictates the mechanism of butyrate&#x02010;mediated histone acetylation and cell proliferation</article-title>. 
<source>Mol Cell</source>. 
<year>2012</year>;
<volume>48</volume>:<fpage>612</fpage>&#x02013;<lpage>626</lpage>.
<pub-id pub-id-type="pmid">23063526</pub-id></mixed-citation></ref><ref id="mc22666-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="mc22666-cit-0041">
<string-name>
<surname>Fateh</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Feizi</surname>
<given-names>MA</given-names>
</string-name>, 
<string-name>
<surname>Safaralizadeh</surname>
<given-names>R</given-names>
</string-name>, 
<string-name>
<surname>Azarbarzin</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Ravanbakhsh</surname>
<given-names>R</given-names>
</string-name>. <article-title>Diagnostic and prognostic value of miR&#x02010;1287 in colorectal cancer</article-title>. 
<source>J Gastrointest Cancer</source>. 
<year>2016</year>;
<volume>47</volume>:<fpage>399</fpage>&#x02013;<lpage>403</lpage>.
<pub-id pub-id-type="pmid">27251300</pub-id></mixed-citation></ref><ref id="mc22666-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="mc22666-cit-0042">
<string-name>
<surname>Ma</surname>
<given-names>W</given-names>
</string-name>, 
<string-name>
<surname>Yu</surname>
<given-names>Q</given-names>
</string-name>, 
<string-name>
<surname>Jiang</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>MiR&#x02010;517a is an independent prognostic marker and contributes to cell migration and invasion in human colorectal cancer</article-title>. 
<source>Oncol Lett</source>. 
<year>2016</year>;
<volume>11</volume>:<fpage>2583</fpage>&#x02013;<lpage>2589</lpage>.
<pub-id pub-id-type="pmid">27073521</pub-id></mixed-citation></ref><ref id="mc22666-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="mc22666-cit-0043">
<string-name>
<surname>Xiang</surname>
<given-names>KM</given-names>
</string-name>, 
<string-name>
<surname>Li</surname>
<given-names>XR</given-names>
</string-name>. <article-title>MiR&#x02010;133b acts as a tumor suppressor and negatively regulates TBPL1 in colorectal cancer cells</article-title>. 
<source>Asian Pac J Cancer Prev</source>. 
<year>2014</year>;
<volume>15</volume>:<fpage>3767</fpage>&#x02013;<lpage>3772</lpage>.
<pub-id pub-id-type="pmid">24870791</pub-id></mixed-citation></ref><ref id="mc22666-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="mc22666-cit-0044">
<string-name>
<surname>Wang</surname>
<given-names>Q</given-names>
</string-name>, 
<string-name>
<surname>Zhang</surname>
<given-names>H</given-names>
</string-name>, 
<string-name>
<surname>Shen</surname>
<given-names>X</given-names>
</string-name>, 
<string-name>
<surname>Ju</surname>
<given-names>S</given-names>
</string-name>. <article-title>Serum microRNA&#x02010;135a&#x02010;5p as an auxiliary diagnostic biomarker for colorectal cancer</article-title>. 
<source>Ann Clin Biochem</source>. 
<year>2017</year>;
<volume>54</volume>:<fpage>76</fpage>&#x02013;<lpage>85</lpage>.
<pub-id pub-id-type="pmid">27126269</pub-id></mixed-citation></ref></ref-list></back></article>